Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Consumer Business An Asset To Pfizer, A Divestment Chip To Analysts

Executive Summary

CEO Ian Read says selling the consumer business has to do more than boost Pfizer's treasury. "If there is a better mix, we are always open to it, but it has to be for strategic reasons rather than cash," he says.

Advertisement

Related Content

Pfizer Keeps Hands On Consumer Product Wheel In Opting Against Split
The Fall Of Pfizergan: The Beginning, The End And Everything In Between
Light Still On For Switches After Pfizer Pulls Plug On OTC Lipitor

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register